http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-36326-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdb0883d711ede20eea6df329c8d5fca
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
filingDate 2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ee7fcefbf416f62b59b1ad9be13004c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4195f906c64ec6ec6cceb62575bf697f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c0e7e34e6a021b8fde48c0ee1dfe403
publicationDate 2016-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UY-36326-A
titleOfInvention N-ALQUILARIL-5-OXIARIL-OCTAHIDRO CICLOPENTA [C] PIRROL NEGATIVE ALOSTERIC MODULATORS OF NR2B
abstract The present invention relates to a negative allosteric modulator of N-alkylaryl-5-oxyaryl-octadihydrocyclopentane [c] pyrrole for NR2B receptors, which are important in the treatment of neurological diseases and have the following formula: Where R1, R2, L1 , L2, X, Y and Y 'are described herein.
priorityDate 2014-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410031093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8027

Total number of triples: 30.